Sarda Proteins
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Sarda Proteins Limited announced that its managing director, Chirag Thummar, resigned from the board on July 4, 2026, with the board immediately appointing Shirish Savaliya as the new managing director for a five-year term. The board also approved an increase in authorised equity share capital from ₹13 crore to ₹100 crore and altered the objects clause of the memorandum of association. In parallel, Yagnik Satasiya was moved from chief financial officer to the post of non-executive chairperson, and Drashti Delvadiya was named as the new CFO. Three other directors—Bipinkumar Savalia, Khilan Savaliya, and independent director Chintan Bhatt—also resigned effective immediately. These sweeping board and management changes come shortly after Onix Renewable Limited completed its open offer for a 19.28% stake in the company.
Powered by Tijori
Sarda Proteins Limited announced that its managing director, Chirag Thummar, resigned from the board on July 4, 2026, with the board immediately appointing Shirish Savaliya as the new managing director for a five-year term. The board also approved an increase in authorised equity share capital from ₹13 crore to ₹100 crore and altered the objects clause of the memorandum of association. In parallel, Yagnik Satasiya was moved from chief financial officer to the post of non-executive chairperson, and Drashti Delvadiya was named as the new CFO. Three other directors—Bipinkumar Savalia, Khilan Savaliya, and independent director Chintan Bhatt—also resigned effective immediately. These sweeping board and management changes come shortly after Onix Renewable Limited completed its open offer for a 19.28% stake in the company.
Powered by Tijori
Dec 24 (Reuters) - Sarda Proteins Ltd SARP.BO:
SARDA PROTEINS LTD -TO ISSUE 350,000 EQUITY SHARES
SARDA PROTEINS LTD -TO ISSUE OF 8.3 MILLION CONVERTIBLE WARRANTS
Source text: ID:nBSE6F2gbf
Further company coverage: SARP.BO
(([email protected];))
Dec 24 (Reuters) - Sarda Proteins Ltd SARP.BO:
SARDA PROTEINS LTD -TO ISSUE 350,000 EQUITY SHARES
SARDA PROTEINS LTD -TO ISSUE OF 8.3 MILLION CONVERTIBLE WARRANTS
Source text: ID:nBSE6F2gbf
Further company coverage: SARP.BO
(([email protected];))
Dec 18 (Reuters) - Sarda Proteins Ltd SARP.BO:
BOARD TO CONSIDER FUND RAISING ON DEC 24
Source text: ID:nBSEv6VsT
Further company coverage: SARP.BO
(([email protected];;))
Dec 18 (Reuters) - Sarda Proteins Ltd SARP.BO:
BOARD TO CONSIDER FUND RAISING ON DEC 24
Source text: ID:nBSEv6VsT
Further company coverage: SARP.BO
(([email protected];;))
Sept 4 (Reuters) - Sarda Proteins Ltd SARP.BO:
NAMES CHIRAG THUMAR AS MD
Source text for Eikon: ID:nBSE9D9dLs
Further company coverage: SARP.BO
(([email protected];;))
Sept 4 (Reuters) - Sarda Proteins Ltd SARP.BO:
NAMES CHIRAG THUMAR AS MD
Source text for Eikon: ID:nBSE9D9dLs
Further company coverage: SARP.BO
(([email protected];;))
July 15 (Reuters) - Sarda Proteins Ltd SARP.BO:
CFO SHIPRA GANDHI RESIGNS
Source text for Eikon: ID:nBSE2KcvmF
Further company coverage: SARP.BO
(([email protected];;))
July 15 (Reuters) - Sarda Proteins Ltd SARP.BO:
CFO SHIPRA GANDHI RESIGNS
Source text for Eikon: ID:nBSE2KcvmF
Further company coverage: SARP.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Sarda Proteins do?
Sarda Proteins Ltd specializes in the manufacturing and marketing of mustard oil.
Who are the competitors of Sarda Proteins?
Sarda Proteins major competitors are Yashhtej Inds. (I), Raj Oil Mills, Ambar Protein Inds., Diligent Industries, NK Industries, Sanwaria Consumer, Poona Dal &Oil Inds.. Market Cap of Sarda Proteins is ₹88 Crs. While the median market cap of its peers are ₹48 Crs.
Is Sarda Proteins financially stable compared to its competitors?
Sarda Proteins seems to be less financially stable compared to its competitors. Altman Z score of Sarda Proteins is 0.57 and is ranked 6 out of its 8 competitors.
Does Sarda Proteins pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sarda Proteins latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Sarda Proteins allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Sarda Proteins balance sheet?
Sarda Proteins balance sheet is weak and might have solvency issues
Is the profitablity of Sarda Proteins improving?
The profit is oscillating. The profit of Sarda Proteins is ₹2.79 Crs for TTM, ₹0.01 Crs for Mar 2025 and ₹0.02 Crs for Mar 2024.
Is the debt of Sarda Proteins increasing or decreasing?
The net debt of Sarda Proteins is decreasing. Latest net debt of Sarda Proteins is -₹7.35 Crs as of Mar-26. This is less than Mar-25 when it was -₹0.07 Crs.
Is Sarda Proteins stock expensive?
Yes, Sarda Proteins is expensive. Latest PE of Sarda Proteins is 137, while 3 year average PE is 81.56. Also latest EV/EBITDA of Sarda Proteins is 280 while 3yr average is 48.18.
Has the share price of Sarda Proteins grown faster than its competition?
Sarda Proteins has given better returns compared to its competitors. Sarda Proteins has grown at ~53.45% over the last 7yrs while peers have grown at a median rate of 18.0%
Is the promoter bullish about Sarda Proteins?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Sarda Proteins?
There is Insufficient data to gauge this.